https://ir.appliedtherapeutics.com/news-releases/news-release-details/applied-therapeutics-receives-complete-response-letter-us-fda

https://investors.arcutis.com/news-releases/news-release-details/arcutis-announces-third-quarter-2024-financial-results-and

https://investors.arcutis.com/news-releases/news-release-details/fda-accepts-arcutis-supplemental-new-drug-application-zoryver

https://investors.arcutis.com/news-releases/news-release-details/arcutis-announces-health-canada-approval-zoryver-roflumilast

https://investors.arcutis.com/news-and-presentations/news-releases

https://www.anavex.com/post/anavex-life-sciences-announces-submission-of-blarcamesine-maa-for-treatment-of-alzheimer-s-disease-t

https://www.mckesson.com/about-mckesson/newsroom/press-releases/2024/mckesson-corporation-reports-fiscal-2025-second-quarter-results/

https://finance.yahoo.com/news/waters-corporation-wat-surged-improved-141241598.html

https://ir.waters.com/newsroom/newsroom/default.aspx

https://investors.modernatx.com/news/news-details/2024/Moderna-Receives-Health-Canada-Approval-for-RSV-Vaccine-for-Adults-Aged-60-Years-and-Older/default.aspx

https://investors.modernatx.com/news/news-details/2024/Moderna-Reports-Third-Quarter-2024-Financial-Results-and-Provides-Business-Updates/default.aspx

https://www.biospace.com/business/moderna-slashes-r-d-budget-by-1-1b-eyes-10-approvals-through-2027

https://www.amgen.com/newsroom/press-releases
